Skip to Content

ZA07 (Divalproex Sodium Delayed-Release 250 mg)

Pill with imprint ZA07 is White, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Zydus Pharmaceuticals.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA07

Divalproex sodium delayed-release 250 mg ZA07

Divalproex Sodium Delayed-Release

Imprint
ZA07
Strength
250 mg
Color
White
Size
14.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals
National Drug Code (NDC)
68382-0032
Inactive Ingredients
ammonia, butyl alcohol, microcrystalline cellulose, ferrosoferric oxide, hypromelloses, isopropyl alcohol, magnesium stearate, methacrylic acid, polyethylene glycol, povidone, propylene glycol, shellac, silicon dioxide, sodium starch glycolate type A potato, corn starch, magnesium silicate, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.